France· FR:61818407
PINAVERIUM ARROW 100 mg, comprimé pelliculé
A pinaverium product containing bromure de pinavérium, registered in France by ARROW GENERIQUES, on the national reimbursement list. The same ATC class is registered in 3 of our 19 countries.
Checked against Base de données publique des médicaments — BDPM (France) on
Informational only — not a medical device.
Where it is registered
Pinaverium is registered in 3 of 19 countries.
Countries holding a registration under ATC A03AX04 (pinaverium), each read from that country’s own register.
- This record: France, from Base de données publique des médicaments — BDPM (France)
- 2 of them publish a price we can compare per daily dose
Pinaverium · ATC A03AX04
3 / 19 countries
- Canada
- Franceprice
- Switzerlandprice
Price per daily dose
What a daily dose of pinaverium costs, country by country.
Normalised to the WHO defined daily dose (0.15 g), the median price runs from $0.24 in France to $1.32 in Switzerland — a ×5.5 gap.
- France: $0.24 per daily dose (median across products in the class)
- Public list prices, converted to USD at the rate date shown
Pinaverium · price per daily dose (0.15 g)
USD · FX 28 Sept 2026
- CH Switzerland$1.32
- FR France$0.24
The record
At a glance
Base de données publique des médicaments — BDPM (France)- Active substance
- BROMURE DE PINAVÉRIUM
- Manufacturer
- ARROW GENERIQUES
- Country
- France (FR)
- ATC code
- A03AX04
- ATC class
- Pinaverium
- Defined daily dose
- 0.15 g, O
- Reimbursed
- Yes
- Source register
- Base de données publique des médicaments — BDPM (France)
- Last checked
- September 12, 2026
Packs & prices · 2
2 priced- cip133400930322246plaquette(s) thermoformée(s) PVC polyéthylène PVDC aluminium de 30 comprimé(s)EUR 4.19
- cip133400937050371plaquette(s) thermoformée(s) PVC-Aluminium de 30 comprimé(s)EUR 4.19
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under A03AX04
Pinaverium, as other registers publish it.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of Base de données publique des médicaments — BDPM (France). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/dd838d9c-c5b4-4c40-aed0-b93ed62abbf8 GET /v1/drugs/dd838d9c-c5b4-4c40-aed0-b93ed62abbf8?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"cis": "61818407",
"date_amm": "2005-11-03",
"type_amm": "Procédure nationale",
"numero_ue": null,
"substance": "BROMURE DE PINAVÉRIUM",
"atc_source": "fr_atc_restore_2026-09-06",
"statut_amm": "Autorisation active",
"statut_bdm": null,
"forme_pharmaceutique": "comprimé pelliculé",
"voies_administration": "orale",
"etat_commercialisation": "Commercialisée",
"surveillance_renforcee": "Non"
}See everything about pinaverium.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.